These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10617131)

  • 21. Enzyme-based diagnosis of classical late infantile neuronal ceroid lipofuscinosis: comparison of tripeptidyl peptidase I and pepstatin-insensitive protease assays.
    Sohar I; Lin L; Lobel P
    Clin Chem; 2000 Jul; 46(7):1005-8. PubMed ID: 10894849
    [No Abstract]   [Full Text] [Related]  

  • 22. Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis.
    Lin L; Lobel P
    Biochem J; 2001 Jul; 357(Pt 1):49-55. PubMed ID: 11415435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution and development of CLN2 protein, the late-infantile neuronal ceroid lipofuscinosis gene product.
    Kurachi Y; Oka A; Itoh M; Mizuguchi M; Hayashi M; Takashima S
    Acta Neuropathol; 2001 Jul; 102(1):20-6. PubMed ID: 11547947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder.
    Sleat DE; Gin RM; Sohar I; Wisniewski K; Sklower-Brooks S; Pullarkat RK; Palmer DN; Lerner TJ; Boustany RM; Uldall P; Siakotos AN; Donnelly RJ; Lobel P
    Am J Hum Genet; 1999 Jun; 64(6):1511-23. PubMed ID: 10330339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of late-infantile neuronal ceroid lipofuscinosis: a new sensitive method to assay lysosomal pepstatin-insensitive proteinase activity in human and animal specimens by capillary electrophoresis.
    Viglio S; Marchi E; Wisniewski K; Casado B; Cetta G; Iadarola P
    Electrophoresis; 2001 Jul; 22(11):2343-50. PubMed ID: 11504071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel nonsense mutation (Q509X) in three Italian late-infantile neuronal ceroid-lipofuscinosis children.
    Tessa A; Simonati A; Tavoni A; Bertini E; Santorelli FM
    Hum Mutat; 2000 Jun; 15(6):577. PubMed ID: 10862088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A lysosomal pepstatin-insensitive proteinase as a novel biomarker for breast carcinoma.
    Junaid MA; Clark GM; Pullarkat RK
    Int J Biol Markers; 2000; 15(2):129-34. PubMed ID: 10883885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CLN2/TPP1 deficiency: the novel mutation IVS7-10A>G causes intron retention and is associated with a mild disease phenotype.
    Bessa C; Teixeira CA; Dias A; Alves M; Rocha S; Lacerda L; Loureiro L; Guimarães A; Ribeiro MG
    Mol Genet Metab; 2008 Jan; 93(1):66-73. PubMed ID: 17959406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dipeptidyl-peptidase I does not functionally compensate for the loss of tripeptidyl-peptidase I in the neurodegenerative disease late-infantile neuronal ceroid lipofuscinosis.
    Kim KH; Pham CT; Sleat DE; Lobel P
    Biochem J; 2008 Oct; 415(2):225-32. PubMed ID: 18570628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glial fibrillary acidic protein is elevated in the lysosomal storage disease classical late-infantile neuronal ceroid lipofuscinosis, but is not a component of the storage material.
    Xu S; Sleat DE; Jadot M; Lobel P
    Biochem J; 2010 May; 428(3):355-62. PubMed ID: 20370715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid immunologic diagnosis of classic late infantile neuronal ceroid lipofuscinosis.
    Kurachi Y; Oka A; Mizuguchi M; Ohkoshi Y; Sasaki M; Itoh M; Hayashi M; Goto Y; Takashima S
    Neurology; 2000 Apr; 54(8):1676-80. PubMed ID: 10762513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel CLN2/TPP1 mutation in a patient with late infantile neuronal ceroid lipofuscinosis.
    Yu F; Liu XM; Chen YH; Zhang SQ; Wang K
    Neurol Sci; 2015 Oct; 36(10):1917-9. PubMed ID: 26032578
    [No Abstract]   [Full Text] [Related]  

  • 33. Mutation of the glycosylated asparagine residue 286 in human CLN2 protein results in loss of enzymatic activity.
    Tsiakas K; Steinfeld R; Storch S; Ezaki J; Lukacs Z; Kominami E; Kohlschütter A; Ullrich K; Braulke T
    Glycobiology; 2004 Apr; 14(4):1C-5C. PubMed ID: 14736728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biosynthesis, glycosylation, and enzymatic processing in vivo of human tripeptidyl-peptidase I.
    Golabek AA; Kida E; Walus M; Wujek P; Mehta P; Wisniewski KE
    J Biol Chem; 2003 Feb; 278(9):7135-45. PubMed ID: 12488460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural organization and sequence of CLN2, the defective gene in classical late infantile neuronal ceroid lipofuscinosis.
    Liu CG; Sleat DE; Donnelly RJ; Lobel P
    Genomics; 1998 Jun; 50(2):206-12. PubMed ID: 9653647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. R208X mutation in CLN2 gene associated with reduced cerebrospinal fluid pterins in a girl with classic late infantile neuronal ceroid lipofuscinosis.
    Barisić N; Logan P; Pikija S; Skarpa D; Blau N
    Croat Med J; 2003 Aug; 44(4):489-93. PubMed ID: 12950156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-trimester diagnosis of late-infantile neuronal ceroid lipofuscinosis (LINCL) by tripeptidyl peptidase I assay and CLN2 mutation analysis.
    Kleijer WJ; van Diggelen OP; Keulemans JL; Losekoot M; Garritsen VH; Stroink H; Majoor-Krakauer D; Franken PF; Eurlings MC; Taschner PE; Los FJ; Galjaard RJ
    Prenat Diagn; 2001 Feb; 21(2):99-101. PubMed ID: 11241534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The substrate range of tripeptidyl-peptidase I.
    Bernardini F; Warburton MJ
    Eur J Paediatr Neurol; 2001; 5 Suppl A():69-72. PubMed ID: 11589011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and analysis of CLN2 variants in CHO cells: Q100R represents a polymorphism, and G389E and R447H represent loss-of-function mutations.
    Lin L; Lobel P
    Hum Mutat; 2001 Aug; 18(2):165. PubMed ID: 11462245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exclusion of late infantile neuronal ceroid lipofuscinosis (LINCL) in a fetus by assay of tripeptidyl peptidase I in chorionic villi.
    Young EP; Winchester BG; Peter Logan W; Wheeler RB; Lake BD
    Prenat Diagn; 2000 Apr; 20(4):337-9. PubMed ID: 10740208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.